Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer.

Br J Cancer · 2003 · PMC2377089 · PMID 12644815

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In addition, a highly significant difference was found between DNA-adduct levels of platinum, as measured in peripheral white blood cells (WBC) by AAS in responders ( n =10) and non-responders ( n =19).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.